Greg Crawford is a collaborator on a Genome Medicine study characterizing chromatin features of both CpG-rich and CpG-poor promoters of genes that undergo silencing in colon cancer.
In Current Opinion in Chemical Biology, Jingdong Tian and colleagues say that microchip-based gene synthesis technologies hold the potential to significantly increase the throughput and decrease the cost of gene synthesis.
In Human Genetics, Laura Beskow and colleagues offer seven recommendations, which cover informed consent disclosures and choices, the process for how and by whom participants are recontacted, the disclosure of individual genetic research results, and the importance of tailoring approaches based on specific contextual factors.
In Molecular Psychiatry, Ahmad Hariri and colleagues say that neurogenetics research is poised to exponentially increase our understanding of how genetic variation interacts with the environment to shape the brain, behavior and risk for psychopathology.
Arthur Moseley is a member of a team that reported results in PLoS ONE suggesting that the capacity of arrayed peptide ligands to capture and subsequently identify proteins by mass spectrometry is relatively broad and robust.
In the Philosophical Transactions of The Royal Society B Biological Sciences, Philip Benfey and colleagues report on work they say "lays the foundation for future identification of important genetic components of root system architecture traits under nutrient limitation using a mapping population derived from these two accessions."
In BMC Bioinformatics, Joe Lucas, Arthur Moseley and colleagues propose a model that they say represents an advance in the ability of statistical models of proteomic data to identify and utilize correlation between features.
© 2004-2013, Duke Institute for Genome Sciences & Policy. Duke University | Duke Medicine | Interdisciplinary Studies at Duke